Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

28.10.21	Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
19.10.21	Gilead To Donate Remdesivir To Help Address COVID-19 Crisis In Indonesia And Armenia (RTTNews)
18.10.21	Gilead Sciences: FDA Approves Low-dose Tablet Dosage Form Of Biktarvy For Pediatric patients (RTTNews)
15.10.21	GILD : Sacituzumab Govitecan Gets Positive CHMP Opinion For Triple-Negative Breast Cancer Treatment (RTTNews)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
22.09.21	Gilead Says Veklury Significantly Reduced Risk Of Hospitalization In High-Risk Patients With COVID (RTTNews)
16.09.21	Gilead: New Data Shows Survival Benefit With Trodelvy - Quick Facts (RTTNews)
05.08.21	Gilead's Unit Kite, And Appia Bio Join For Stem Cell Therapy Research (RTTNews)
30.07.21	Gilead Sciences Updates FY Outlook (RTTNews)
29.07.21	Gilead Sciences Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
19.07.21	BioNTech To Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform, Gaithersburg Facility (RTTNews)
28.06.21	Kite's CAR T-cell Therapy Improves Survival By 60% Over Chemotherapy Plus Stem Cell Transplant (RTTNews)
24.06.21	Gilead : Treatment With Bulevirtide Achieves Significant Response In Chronic Hepatitis Delta Virus (RTTNews)
23.06.21	Fosun Kite Biotechnology Gets CAR T-cell Therapy Approval In China (RTTNews)
21.06.21	Gilead's Remdesivir Reduces Mortality Rate In Hospitalized Patients With COVID-19 (RTTNews)
17.06.21	Kite, Shoreline Biosciences In Strategic Partnership To Develop Novel Allogeneic Cell Therapies (RTTNews)
11.06.21	Gilead : FDA Oks Epclusa, Expanding Pediatric Indication To Treat Children With Chronic Hepatitis C (RTTNews)
29.04.21	Gilead Sciences Inc. Q1 adjusted earnings Miss Estimates (RTTNews)
29.04.21	Gilead Science Q1 Profit Rises, Updates FY21 EPS Outlook (RTTNews)
13.04.21	FDA Grants Accelerated Approval To Gilead Sciences' Trodelvy For Treatment Of Urothelial Cancer (RTTNews)
08.04.21	FDA Approves Gilead's Trodelvy To Treat Metastatic Triple-Negative Breast Cancer (RTTNews)
29.03.21	Humanigen: Lenzilumab Improves Survival Without Need For Mechanical Ventilation In COVID-19 Patients (RTTNews)
18.03.21	Gilead Sciences, Novo Collaborate To Study Efficacy Of Cilofexor, Firsocostat In NASH Patients (RTTNews)
11.03.21	Roche: REMDACTA Trial Fails To Meet Endpoints In Patients With Severe COVID-19 Pneumonia (RTTNews)
11.02.21	BPTH On Steady Path, CGIX On Watch, GLPG/GILD Scrap IPF Drug, REGN's Libtayo Gets FDA Nod (RTTNews)
10.02.21	Galapagos, Gilead Discontinue Late-stage Trials In Idiopathic Pulmonary Fibrosis (RTTNews)
04.02.21	Gilead Sciences Inc. Q4 adjusted earnings of $2.19 per share (RTTNews)
01.02.21	Gilead & Gritstone Partner To Develop HIV-specific Therapeutic Vaccine - Quick Facts (RTTNews)
12.01.21	Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus - Quick Facts (RTTNews)
11.01.21	Gilead Sciences Revises FY20 Guidance - Quick Facts (RTTNews)
06.01.21	Kite Announces Research Collaboration With Oxford BioTherapeutics - Quick Facts (RTTNews)
16.12.20	Kite: European Commission Grants Conditional Marketing Authorization For Tecartus (RTTNews)
16.12.20	Gilead Says Not To Pursue FDA Approval Of Filgotinib For Rheumatoid Arthritis Treatment (RTTNews)
10.12.20	Gilead Sciences To Buy Hepatitis Drug Maker MYR GmbH For Up To EUR 1.45 Bln (RTTNews)
01.12.20	Canada Approves Gilead Sciences' Descovy For HIV Pre-exposure Prophylaxis (RTTNews)
20.11.20	WHO Recommends Against Using Gilead Sciences' Remdesivir For Covid (RTTNews)
20.11.20	AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B (RTTNews)
20.11.20	FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment (RTTNews)
18.11.20	Gilead Sciences' Lenacapavir Meets Primary Endpoint In Phase 2/3 HIV Study (RTTNews)
16.11.20	New Drugs Approved In October (RTTNews)
10.11.20	Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients (RTTNews)
28.10.20	Gilead Sciences Inc. Q3 adjusted earnings of $2.11 per share (RTTNews)
28.10.20	Gilead Sciences Swings To Q3 Profit (RTTNews)
27.10.20	Eli Lilly Ends Late-stage Covid-19 Antibody Trial In U.S. Due To Insufficient Data (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
23.10.20	Stock Alert: Gilead Sciences Shares Up 3% (RTTNews)
23.10.20	Gilead Completes Transaction To Acquire Immunomedics - Quick Facts (RTTNews)
23.10.20	FDA OKs Gilead's Remdesivir As First COVID-19 Treatment Despite WHO Findings (RTTNews)
23.10.20	Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI… (RTTNews)
22.10.20	FDA Approves Gilead's Antiviral Remdesivir For Treatment Of COVID-19 - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester